Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents

OBJECTIVE—Impaired glucose tolerance (IGT) is a pre-diabetic state of increasing prevalence among obese adolescents. The purpose of this study was to determine the natural history of progression from normal glucose tolerance (NGT) to IGT in obese adolescents. RESEARCH DESIGN AND METHODS—We determined the evolution of β-cell function, insulin sensitivity (SI), and glucose tolerance in a multiethnic group of 60 obese adolescents over the course of approximately 30 months. Each subject underwent three serial 3-h oral glucose tolerance tests. Dynamic, static, and total β-cell responsivity (Φd, Φs, and Φtot, respectively) and Si were assessed by oral C-peptide and glucose minimal models. The disposition index (DI), which adjusts insulin secretion for Si, was calculated. RESULTS—At baseline, all 60 subjects had NGT. Seventy-seven percent (46 subjects) maintained NGT over the three testing periods (nonprogressors), whereas 23% (14 subjects) developed IGT over time (progressors). At baseline, percent fat and BMI Z score were comparable between the groups. Fasting plasma glucose, 2-h glucose, glucose area under the curve at 180 min, and Φd were significantly different between the two groups at baseline, whereas Si was comparable between the two groups. Over time, although Si remained unchanged in nonprogressors, it steadily worsened by ∼45% (P > 0.04) in progressors. β-Cell responsivity decreased by 20% in progressors, whereas it remained stable in nonprogressors. The DI showed a progressive decline in progressors compared with a modest improvement in nonprogressors (P = 0.02). CONCLUSIONS—Obese adolescents who progress to IGT may manifest primary defects in β-cell function. In addition, progressive decline in Si further aggravates β-cell function, contributing to the worsening of glucose intolerance.

[1]  Helen Brown,et al.  Applied Mixed Models in Medicine , 2000, Technometrics.

[2]  E. Horton,et al.  Beta-cell failure in the pathogenesis of type 2 diabetes mellitus , 2004, Current diabetes reports.

[3]  Sonia Caprio,et al.  Beta-cell function across the spectrum of glucose tolerance in obese youth. , 2005, Diabetes.

[4]  Claudio Cobelli,et al.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. , 2005, Diabetes.

[5]  Claudio Cobelli,et al.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. , 2004, American journal of physiology. Endocrinology and metabolism.

[6]  R. Bergman,et al.  Insulin Sensitivity and Acute Insulin Response in African-Americans, Non-Hispanic Whites, and Hispanics With NIDDM: The Insulin Resistance Atherosclerosis Study , 1997, Diabetes.

[7]  Claudio Cobelli,et al.  Insulin sensitivity by oral glucose minimal models: validation against clamp. , 2005, American journal of physiology. Endocrinology and metabolism.

[8]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[9]  W. Tamborlane,et al.  The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  J. Janosky,et al.  Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? , 2005, Diabetes care.

[11]  M. Walker,et al.  Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects , 2006, Diabetologia.

[12]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[13]  S. Bonner-Weir,et al.  Five stages of evolving beta-cell dysfunction during progression to diabetes. , 2004, Diabetes.

[14]  M. Goran,et al.  Persistence of Pre-Diabetes in Overweight and Obese Hispanic Children , 2008, Diabetes.

[15]  S. Haffner,et al.  The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. , 2006, Diabetes.

[16]  C Cobelli,et al.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. , 2001, Diabetes.

[17]  Claudio Cobelli,et al.  Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. , 2007, American journal of physiology. Endocrinology and metabolism.

[18]  Claudio Cobelli,et al.  Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity , 2001 .

[19]  S. Caprio,et al.  Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  W. Tamborlane,et al.  Predictors of changes in glucose tolerance status in obese youth. , 2005, Diabetes care.

[21]  T. Buchanan,et al.  Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. , 2006, Diabetes.

[22]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[23]  J. Janosky,et al.  Youth Type 2 Diabetes Insulin resistance, β-cell failure, or both? , 2005 .

[24]  M. Cnop,et al.  Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. , 2007, Diabetes care.

[25]  W. Tamborlane,et al.  Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. , 2002, The New England journal of medicine.

[26]  S. Bonner-Weir,et al.  Five Stages of Evolving-Cell Dysfunction During Progression to Diabetes , 2004 .

[27]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[28]  C. Bogardus,et al.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. , 2001, Diabetes care.